Want to see AU:IME full AI Analyst Report?
IME Stock Chart & Stats
AU$0.40
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.40
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.21 - AU$0.47
Previous CloseN/A
Volume202.98K
Average Volume (3M)12.74K
Market Cap
AU$17.95M
Enterprise ValueAU$17.42M
Total Cash (Recent Filing)AU$1.99M
Total Debt (Recent Filing)AU$455.34K
Price to Earnings (P/E)94.3
Beta0.34
Next Earnings
Mar 01, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding54,395,714
10 Day Avg. Volume24,287
30 Day Avg. Volume12,737
Financial Highlights & Ratios
PEG Ratio1.98
Price to Book (P/B)1.29
Price to Sales (P/S)0.71
P/FCF Ratio83.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.37Price Target Upside-7.50% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.02
Revenue Forecast (FY)AU$32.60M
Bulls Say, Bears Say
Bulls Say
Accelerating Revenue GrowthRevenue growth accelerated materially in 2025, indicating stronger commercial momentum and expanding activity after a nearly flat prior year. If maintained, this higher growth rate can improve operating leverage, support reinvestment, and strengthen the company’s ability to build a larger recurring revenue base.
Low Financial LeverageVery low leverage provides financial flexibility because less cash is required for interest and debt servicing. The declining debt-to-equity ratio leaves greater capacity to withstand operating volatility, fund strategic initiatives, and preserve shareholder value while the company works toward sustainable profitability.
Positive Operating And Free Cash FlowThe return to positive operating and free cash flow is an important improvement in internal funding capacity. Cash generated from operations can reduce reliance on external capital and help finance ongoing activities, although the durability of this improvement depends on achieving more consistent conversion over time.
Bears Say
Persistent UnprofitabilityPersistent net losses and a negative operating margin show that the business has not yet converted revenue growth into sustainable earnings. Continued losses can consume equity returns, constrain reinvestment, and make future performance more dependent on achieving meaningful operating improvements.
Gross Margin DeteriorationThe sharp gross-margin decline indicates that a smaller share of revenue is being retained after direct costs. Unless reversed, weaker unit economics can limit operating leverage, reduce the benefit of future revenue growth, and make the path to positive operating profitability materially harder.
Volatile Cash ConversionAlthough cash flow improved in 2025, the pack describes substantial volatility and inconsistent conversion across years. This reduces confidence that current cash generation is structurally repeatable and may complicate planning, investment decisions, and the company’s ability to fund growth internally.
ImExHS Limited News
IME FAQ
What was ImExHS Limited’s price range in the past 12 months?
ImExHS Limited lowest share price was AU$0.20 and its highest was AU$0.47 in the past 12 months.
What is ImExHS Limited’s market cap?
ImExHS Limited’s market cap is AU$17.95M.
When is ImExHS Limited’s upcoming earnings report date?
ImExHS Limited’s upcoming earnings report date is Mar 01, 2027 which is in 122 days.
How were ImExHS Limited’s earnings last quarter?
ImExHS Limited released its earnings results on Aug 27, 2026. The company reported AU$0.12 earnings per share for the quarter, beating the consensus estimate of -AU$0.05 by AU$0.17.
Is ImExHS Limited overvalued?
According to Wall Street analysts ImExHS Limited’s price is currently Overvalued.
Does ImExHS Limited pay dividends?
ImExHS Limited does not currently pay dividends.
What is ImExHS Limited’s EPS estimate?
ImExHS Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ImExHS Limited have?
ImExHS Limited has 54,395,714 shares outstanding.
What happened to ImExHS Limited’s price movement after its last earnings report?
ImExHS Limited reported an EPS of AU$0.12 in its last earnings report, beating expectations of -AU$0.05. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of ImExHS Limited?
Currently, no hedge funds are holding shares in AU:IME
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
ImExHS Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$0.37 (-7.50% Downside)
AU$0.37 (-7.50% Downside)
Blogger Sentiment
Bullish
AU:IME Sentiment 100%
Sector Average 65%
Sector Average 65%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
34.69%
12-Months-Change
Fundamentals
Return on Equity
1.14%
Trailing 12-Months
Asset Growth
―
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
ImExHS Limited
ImExHS Limited delivers cloud-powered medical imaging technologies to customers worldwide, including those in Australia. The firm specializes in the development and sale of modular imaging software systems, which encompass comprehensive information management platforms for disciplines such as radiology, cardiology, and pathology, alongside a robust picture archiving and communication system (PACS). Its principal software solutions include AQUILA for radiology, ALULA for pathology, and Antero for cardiology. Moreover, ImExHS offers STELLA.I, a suite of artificial intelligence tools hosted in the cloud, crafted to bolster diagnostic capabilities for medical professionals. The company further extends outsourced radiology and teleradiology services to hospitals and various other healthcare entities. Established in 2001, ImExHS Limited operates from its base in Mascot, Australia.
IME Stock 12 Month Forecast
Average Price Target
AU$0.37
▼(-7.50% Downside)
Technical Analysis
Oneview Healthcare Chess Depository Interests repr 1
―
Mach7 Technologies
―
Beamtree Holdings Ltd
―
Alcidion Group Limited
―
PainChek Ltd
―






